Patients with Laron syndrome, caused by loss-of-function mutations in the GH receptor gene in humans, develop NAFLD and chronic replacement of insulin-like growth factor 1 (IGF-1) does not alleviate NAFLD status (17). Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.